satavaptan: Clinical Trials

7 trials of satavaptan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Completed 4, Terminated 3

Follow satavaptan: new trials by email Literature Review of satavaptan trials Research Report on satavaptan

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
Satavaptan, placebo - Hyponatremia, Inappropriate ADH Syndrome
Phase 3TerminatedSanofi22008-07-012016-05-26
Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
Satavaptan, placebo - Ascites, Liver Cirrhosis
Phase 3TerminatedSanofi2412006-08-012016-05-18
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
Satavaptan, placebo - Ascites, Liver Cirrhosis
Phase 3CompletedSanofi4632006-07-012016-05-26
Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
Satavaptan, placebo - Ascites, Liver Cirrhosis
Phase 3TerminatedSanofi5012006-07-012016-05-24
Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
SR121463B - Inappropriate ADH Syndrome, Hyponatremia
Phase 3CompletedSanofi572005-07-012009-01-21
DILIPO (DILutIonal HyPOnatremia)
SR121463B - Congestive Heart Failure
Phase 3CompletedSanofi1502005-05-012008-09-15
Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
SR121463B - Inappropriate ADH Syndrome, Hyponatremia
Phase 3CompletedSanofi772004-05-012008-12-10

Conditions studied

Hyponatremia (4)  ·  Ascites (3)  ·  Inappropriate ADH Syndrome (3)  ·  Liver Cirrhosis (3)  ·  Heart Failure (1)

Sponsors

Sanofi (7)

Countries

United States (7)  ·  Belgium (6)  ·  Canada (6)  ·  Australia (5)  ·  Hungary (5)  ·  Argentina (4)  ·  Brazil (4)  ·  France (4)  ·  Germany (4)  ·  Portugal (4)  ·  Romania (4)  ·  Spain (4)  ·  Chile (3)  ·  Croatia (3)  ·  Israel (3)

Top investigators

Daniel Ter-Minassian, MD (1)

Results publications

PMID 21836029, PMID 21199833